N-Benzyl-4-oxo-2-thioxo-3-(3-(trifluoromethyl)phenyl)-1,2,3,4-tetrahydroquinazoline-7-carboxamide
97%
Reagent
Code: #215486
CAS Number
403718-45-6
blur_circular Chemical Specifications
scatter_plot
Molecular Information
Weight
455.45 g/mol
Formula
C₂₃H₁₆F₃N₃O₂S
inventory_2
Storage & Handling
Density
1.48±0.1 g/cm3(Predicted)
Storage
2-8°C, sealed, dry
description Product Description
Used in pharmaceutical research as a potent inhibitor of Janus kinase 2 (JAK2), particularly in the development of targeted therapies for inflammatory diseases and certain cancers. Shows promising activity in suppressing cytokine signaling pathways involved in autoimmune disorders such as rheumatoid arthritis and psoriasis. Also investigated for its potential in treating myeloproliferative neoplasms driven by JAK2 mutations. High selectivity enhances its utility in minimizing off-target effects during therapeutic development.
shopping_cart Available Sizes & Pricing
N-Benzyl-4-oxo-2-thioxo-3-(3-(trifluoromethyl)phenyl)-1,2,3,4-tetrahydroquinazoline-7-carboxamide
Used in pharmaceutical research as a potent inhibitor of Janus kinase 2 (JAK2), particularly in the development of targeted therapies for inflammatory diseases and certain cancers. Shows promising activity in suppressing cytokine signaling pathways involved in autoimmune disorders such as rheumatoid arthritis and psoriasis. Also investigated for its potential in treating myeloproliferative neoplasms driven by JAK2 mutations. High selectivity enhances its utility in minimizing off-target effects during therapeutic development.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
Total
฿0.00
THB